{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T21:50:17Z","timestamp":1761429017424},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T00:00:00Z","timestamp":1375488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s40265-013-0104-5","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T11:36:26Z","timestamp":1375443386000},"page":"1483-1490","source":"Crossref","is-referenced-by-count":9,"title":["Sumatriptan Iontophoretic Transdermal System: A Review of Its Use in Patients with Acute Migraine"],"prefix":"10.1007","volume":"73","author":[{"given":"Karly P.","family":"Garnock-Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,3]]},"reference":[{"issue":"11","key":"104_CR1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/11317540-000000000-00000","volume":"24","author":"AM Rapoport","year":"2010","unstructured":"Rapoport AM, Freitag F, Pearlman SH. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. CNS Drugs. 2010;24(11):929\u201340.","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"104_CR2","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1007\/s10072-012-1056-3","volume":"33","author":"AM Rapoport","year":"2012","unstructured":"Rapoport AM. The therapeutic future in headache. Neurol Sci. 2012;33(Suppl 1):S119\u201325.","journal-title":"Neurol Sci."},{"issue":"1","key":"104_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11940-011-0155-4","volume":"14","author":"J Hoffmann","year":"2012","unstructured":"Hoffmann J, Goadsby PJ. New agents for acute treatment of migraine: CGRP receptor antagonists, iNOS inhibitors. Curr Treat Options Neurol. 2012;14(1):50\u20139.","journal-title":"Curr Treat Options Neurol."},{"issue":"1","key":"104_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1526-4610.2012.02292.x","volume":"53","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Buse DC, Saiers J, et al. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53(1):93\u2013103.","journal-title":"Headache"},{"issue":"6","key":"104_CR5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754\u201362.","journal-title":"Neurology"},{"key":"104_CR6","unstructured":"NuPathe. ZECUITY\u2122 (sumatriptan iontophoretic transdermal system): US prescribing information. 2013. http:\/\/www.zecuity.com\/pdf\/Zecuity%20-%20Full%20Prescribing%20Information%20Final%20NuPathe%2017Jan2013_v2.pdf . Accessed 29 Apr 2013."},{"issue":"5","key":"104_CR7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2165\/00003495-199243050-00010","volume":"43","author":"KL Dechant","year":"1992","unstructured":"Dechant KL, Clissold SP. Sumatriptan: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of migraine and cluster headache. Drugs. 1992;43(5):776\u201398.","journal-title":"Drugs."},{"issue":"6","key":"104_CR8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199855060-00020","volume":"55","author":"CM Perry","year":"1998","unstructured":"Perry CM, Markham A. Sumatriptan: an updated review of its use in migraine. Drugs. 1998;55(6):889\u2013922.","journal-title":"Drugs."},{"issue":"4","key":"104_CR9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2165\/00003495-199447040-00006","volume":"47","author":"G Plosker","year":"1994","unstructured":"Plosker G, McTavish D. Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994;47(4):622\u201351.","journal-title":"Drugs."},{"issue":"2","key":"104_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nurt.2010.03.003","volume":"7","author":"L Neeb","year":"2010","unstructured":"Neeb L, Meents J, Reuter U. 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks? Neurother. 2010;7(2):176\u201382.","journal-title":"Neurother"},{"key":"104_CR11","author":"M Sacco","year":"2013","unstructured":"Sacco M, Meschi M, Regolisti G, et al. The relationship between blood pressure and pain. J Clin Hypertens. 2013. doi: 10.1111\/jch.12145 .","journal-title":"J Clin Hypertens"},{"issue":"10","key":"104_CR12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11095-007-9317-1","volume":"24","author":"SJ Siegel","year":"2007","unstructured":"Siegel SJ, O\u2019Neill C, Dube LM, et al. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Pharm Res. 2007;24(10):1919\u201326.","journal-title":"Pharm Res."},{"issue":"6","key":"104_CR13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1526-4610.2009.01437.x","volume":"49","author":"M Pierce","year":"2009","unstructured":"Pierce M, Marbury T, O\u2019Neill C, et al. Zelrix\u2122: a novel transdermal formulation of sumatriptan. Headache. 2009;49(6):817\u201325.","journal-title":"Headache"},{"key":"104_CR14","unstructured":"Pierce M, O\u2019Neill C, Du W, et al. Pharmacokinetic and bioavailability comparison between Zelrix (transdermal sumatriptan) patches used in a phase III clinical study and patches intended for commercial use [abstract no. P9]. Headache. 2011;51(Suppl. s1):8\u20139."},{"key":"104_CR15","unstructured":"Wilks K, Pierce M, O\u2019Neill C, et al. Pharmacokinetics of oral and transdermal sumatriptan during acute migraine and non-migraine periods: incidence of the migraine effect [abstract no. PO-55]. Headache. 2010;50(Suppl. s1):26\u20137."},{"issue":"9","key":"104_CR16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1526-4610.2012.02198.x","volume":"52","author":"J Goldstein","year":"2012","unstructured":"Goldstein J, Smith TR, Pugach N, et al. A sumatriptan iontophoretic transdermal system for the acute treatment of migraine. Headache. 2012;52(9):1402\u201310.","journal-title":"Headache."},{"issue":"2","key":"104_CR17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.2011.02065.x","volume":"52","author":"EA Schulman","year":"2012","unstructured":"Schulman EA. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea. Headache. 2012;52(2):204\u201312.","journal-title":"Headache."},{"issue":"4","key":"104_CR18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1526-4610.2012.02094.x","volume":"52","author":"TR Smith","year":"2012","unstructured":"Smith TR, Goldstein J, Singer R, et al. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache. 2012;52(4):612\u201324.","journal-title":"Headache."},{"key":"104_CR19","unstructured":"Silberstein S, Lipton RB, Newman L, et al. Sumatriptan transdermal system is significantly less likely to cause treatment emergent nausea than placebo [abstract no. P7]. Cephalalgia. 2013;33(8):24\u20135. Plus poster presented at the 2013 International Headache Congress; Jun 27\u201330; Boston, MA."},{"issue":"5","key":"104_CR20","first-page":"877","volume":"52","author":"T Smith","year":"2012","unstructured":"Smith T, Pierce M, Wilks K, et al. Long-term safety of the sumatriptan iontophoretic transdermal patch, np101, for acute migraine: a 12 month repeat use, open label study [abstract no. P13]. Headache. 2012;52(5):877.","journal-title":"Headache"},{"issue":"2","key":"104_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nurt.2010.03.005","volume":"7","author":"MW Pierce","year":"2010","unstructured":"Pierce MW. Transdermal delivery of sumatriptan for the treatment of acute migraine. Neurother. 2010;7(2):159\u201363.","journal-title":"Neurother."},{"key":"104_CR22","first-page":"429","volume":"8","author":"M Vikelis","year":"2012","unstructured":"Vikelis M, Mitsikostas DD, Rapoport AM. Sumatriptan transdermal iontophoretic patch (NP101-Zelrix\u2122): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine. Neuropsychiatr. 2012;8:429\u201334.","journal-title":"Neuropsychiatr."},{"key":"104_CR23","unstructured":"Meadows KP, Pierce M, Foster S, et al. Sumatriptan transdermal system (TDS) can be correctly assembled, applied, and activated during migraine attacks [abstract no. P21]. Cephalalgia. 2013; 33(8):34\u20135. Plus poster presented at the 2013 International Headache Congress; Jun 27\u201330; Boston, MA."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0104-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-013-0104-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0104-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:32Z","timestamp":1559504492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-013-0104-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,3]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1007\/s40265-013-0104-5","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,3]]}}}